LICENSE AND COLLABORATION Agreement between Provention Bio, Inc. anD AMGEN INC. EffectiVe Date: November 5, 2018License and Collaboration Agreement • March 19th, 2019 • Provention Bio, Inc. • Pharmaceutical preparations • New York
This License and Collaboration Agreement (the “Agreement”) is entered into as of November 5, 2018 (the “Effective Date”), by and between Provention Bio, Inc., a corporation organized under the laws of the State of Delaware (“Company”), having an address of P.O. Box 666, Oldwick, New Jersey 08858, and Amgen Inc., a corporation organized under the laws of the State of Delaware (“Amgen”), having an address of One Amgen Center Drive, Thousand Oaks, California 91320.
